Trulieve Cannabis Corp., together with its subsidiaries, operates as a medical cannabis company. It cultivates and produces products in-house and distributes its products to Trulieve branded stores (dispensaries) in Florida, as well as through home delivery. The company produces flower, edible, vaporizer cartridge, concentrate, topical, capsule, tincture, dissolvable powder, and nasal spray products under the Avenue, Cultivar Collection, Muse, Modern Flower, Alchemy, Momenta, Sweet Talk, Co2lors, Loveli, and Roll One brands. As of March 16, 2022, it operated 162 dispensaries, which included 113 dispensaries in Florida, 19 affiliated dispensaries in Pennsylvania, 17 dispensaries in Arizona, five dispensaries in California, three dispensaries in Maryland, two dispensaries in Massachusetts, two dispensaries in West Virginia, and one dispensary in Connecticut. Trulieve Cannabis Corp. also operated cultivation and processing facilities in Arizona, Colorado, Florida, Maryland, Massachusetts, Nevada, Pennsylvania, and West Virginia. The company was formerly known as Schyan Exploration Inc./Exploration Schyan Inc. and changed its name to Trulieve Cannabis Corp. in September 2018. Trulieve Cannabis Corp. was incorporated in 1940 and is headquartered in Quincy, Florida.
P/B ratio for Trulieve Cannabis Corp. (TRUL.CN)
P/B ratio as of 2023: 0.70
According to Trulieve Cannabis Corp.'s latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.70. At the end of 2022 the company had a P/B ratio of 0.73.
P/B ratio history for Trulieve Cannabis Corp. from 2016 to 2023
P/B ratio at the end of each year
| Year | P/B ratio |
|---|---|
| 2023 | 0.70 |
| 2022 | 0.73 |
| 2021 | 1.73 |
| 2020 | 8.00 |
| 2019 | 4.62 |
| 2018 | 10.73 |
| 2017 | -4359.07 |
| 2016 | -5355.50 |